Coronado Research has appointed Nick Littlebury as EVP, Regulatory Affairs. Littlebury is a senior regulatory leader with strategic and operational experience across the pharmaceutical industry’s product lifecycle.

Coronado Research CEO Andrew MacGarvey said, “His focus on cross-functional collaboration will enable integrated delivery solutions for our clients. He can draw on experience from positions within the Sponsor, Regulatory Authority, and service provision spaces to build optimised solutions for our customers.”

 He has previously led regulatory groups in the UK and Europe and has been responsible for developing and executing global client solutions focusing on innovation.

Littlebury commented, “Andrew has assembled an industry-leading team that provides best-in-class solutions across clinical development, market access, medical affairs, and regulatory, integrating technology expertise to optimize the drug development pathway. Artificial Intelligence (AI) and automation advancements are reshaping how we work. We will support companies in unlocking the full potential of these technologies to reduce regulatory burden, helping them focus on what matters most – the patient.”